Valuation: Celularity Inc.

Market Cap 20.28M 17.57M 16.43M 15.02M 28.27M 1.93B 28.75M 192M 75.5M 967M 76.13M 74.5M 3.23B P/E 2024
-0.79x
P/E 2025 -0.31x
Enterprise Value 88.82M 76.95M 71.95M 65.76M 124M 8.46B 126M 842M 331M 4.24B 333M 326M 14.15B EV / Sales 2024
2.12x
EV / Sales 2025 3.77x
Free-Float
62.72%
Yield 2024 *
-
Yield 2025 -
1 day-2.01%
1 week+8.07%
Current month+8.07%
1 month-8.18%
3 months-21.97%
6 months-47.18%
Current year-38.14%
1 week 0.66
Extreme 0.6601
0.78
1 month 0.6
Extreme 0.601
0.84
Current year 0.56
Extreme 0.5601
1.51
1 year 0.56
Extreme 0.5601
4.31
3 years 0.56
Extreme 0.5601
7.97
5 years 0.56
Extreme 0.5601
131.86
10 years 0.56
Extreme 0.5601
134
Manager TitleAgeSince
Chief Executive Officer 66 01/01/2016
Director of Finance/CFO 67 27/02/2026
Compliance Officer 42 01/07/2021
Director TitleAgeSince
Chairman 66 01/01/2016
Director/Board Member 64 01/07/2017
Director/Board Member 73 03/06/2022
Date Insider Type Main position Quantity % Market Cap.
12/01/26 Free

Director

19,231 0.0667%
12/01/26 Free

Director

30,000 0.1040%
12/01/26 Free

Director

19,231 0.0667%
Change 5-day change 1-year change 3-year change Capi.($)
-2.01%+8.07%-78.81%-79.35% 20.28M
+3.02%+5.96%+43.53%+2.86% 78.32B
+0.84%+5.66%-0.15%+27.88% 51.1B
+0.90%+0.99%+22.01%+176.13% 49.18B
+1.72%+9.27%-48.46%-48.80% 44.71B
-0.39%+2.06%+58.51%-23.65% 30.72B
+0.82%+1.70%+55.06%+85.80% 24.44B
+1.08%+9.10%+128.98%-41.26% 23.62B
+2.58%+12.23%+6.63%+202.17% 21.05B
-0.62%-4.29%+65.10%+117.79% 16.61B
Average +0.79%+3.59%+25.24%+41.96% 33.98B
Weighted average by Cap. +1.41%+4.34%+28.63%+43.36%

Financials

2024 2025
Net sales 54.22M 46.97M 43.92M 40.14M 75.58M 5.17B 76.86M 514M 202M 2.59B 204M 199M 8.64B 26.55M 23M 21.51M 19.66M 37.01M 2.53B 37.63M 252M 98.83M 1.27B 99.66M 97.52M 4.23B
Net income -57.89M -50.16M -46.9M -42.86M -80.7M -5.52B -82.06M -549M -215M -2.76B -217M -213M -9.22B -91.72M -79.46M -74.3M -67.9M -128M -8.74B -130M -870M -341M -4.37B -344M -337M -14.61B
Net Debt 68.1M 59M 55.17M 50.42M 94.92M 6.49B 96.53M 646M 253M 3.25B 256M 250M 10.85B 68.54M 59.38M 55.52M 50.74M 95.54M 6.53B 97.15M 650M 255M 3.27B 257M 252M 10.92B
Logo Celularity Inc.
Celularity Inc. is a regenerative and cellular medicine company. The Company is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells, T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. Its IMPACT manufacturing platform is a fully integrated process designed to optimize the speed of the sourcing of placentas from full-term healthy informed consent donors through the use of proprietary processing methods, cell selection, product-specific chemistry, manufacturing and control (CMC), advanced cell manufacturing and cryopreservation. It also provides contract manufacturing and development services to third parties.
Employees
115
Date Price Change Volume
10/08/26 $0.6866 -2.01% 25,668
07/08/26 $0.7007 +2.59% 18,067
06/08/26 $0.6830 -6.97% 25,838
05/08/26 $0.7342 +4.38% 10,292
04/08/26 $0.7034 +6.54% 77,815

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CELU Stock